BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24243732)

  • 1. Direct visualization of hepatitis C virus-infected Huh7.5 cells with a high titre of infectious chimeric JFH1-EGFP reporter virus in three-dimensional Matrigel cell cultures.
    Liu S; Chen R; Hagedorn CH
    J Gen Virol; 2014 Feb; 95(Pt 2):423-433. PubMed ID: 24243732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.
    Liu S; Xiao L; Nelson C; Hagedorn CH
    PLoS One; 2012; 7(9):e44965. PubMed ID: 23028707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.
    Gottwein JM; Jensen TB; Mathiesen CK; Meuleman P; Serre SB; Lademann JB; Ghanem L; Scheel TK; Leroux-Roels G; Bukh J
    J Virol; 2011 Sep; 85(17):8913-28. PubMed ID: 21697486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release.
    Wang Q; Li Y; Liu SA; Xie W; Cheng J
    World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.
    Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J
    J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
    Bungyoku Y; Shoji I; Makine T; Adachi T; Hayashida K; Nagano-Fujii M; Ide YH; Deng L; Hotta H
    J Gen Virol; 2009 Jul; 90(Pt 7):1681-1691. PubMed ID: 19282429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
    Shirasago Y; Fukazawa H; Aizaki H; Suzuki T; Suzuki T; Sugiyama K; Wakita T; Hanada K; Abe R; Fukasawa M
    J Gen Virol; 2018 Oct; 99(10):1407-1417. PubMed ID: 30045785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adapted HCV JFH1 variant is capable of accommodating a large foreign gene insert and allows lower level HCV replication and viral production.
    Wang Q; Hagedorn C; Liu S
    Int J Biol Sci; 2018; 14(10):1211-1220. PubMed ID: 30123070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.
    Liu S; Nelson CA; Xiao L; Lu L; Seth PP; Davis DR; Hagedorn CH
    Antiviral Res; 2011 Jan; 89(1):54-63. PubMed ID: 21075143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
    Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
    J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
    Li YP; Ramirez S; Mikkelsen L; Bukh J
    J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a viruses.
    Gottwein JM; Jensen SB; Li YP; Ghanem L; Scheel TK; Serre SB; Mikkelsen L; Bukh J
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1291-303. PubMed ID: 23274664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B.
    Han Q; Manna D; Belton K; Cole R; Konan KV
    J Virol; 2013 Jul; 87(13):7409-22. PubMed ID: 23616661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant replication-competent hepatitis C virus expressing Azami-Green, a bright green-emitting fluorescent protein, suitable for visualization of infected cells.
    Hou W; Aoki C; Yu L; Wen X; Xue Y; Gao B; Liu W; Gao GF; Iwamoto A; Kitamura Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):7-11. PubMed ID: 18786508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway.
    Hazari S; Chandra PK; Poat B; Datta S; Garry RF; Foster TP; Kousoulas G; Wakita T; Dash S
    Virol J; 2010 Feb; 7():36. PubMed ID: 20149251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
    Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
    Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.
    Humes D; Ramirez S; Jensen TB; Li YP; Gottwein JM; Bukh J
    Virology; 2018 Sep; 522():177-192. PubMed ID: 30032031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargement.
    Duan X; Anwar MI; Xu Z; Ma L; Yuan G; Chen Y; Liu X; Xia J; Zhou Y; Li YP
    Emerg Microbes Infect; 2018 Aug; 7(1):143. PubMed ID: 30087320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.